Search | Page 8 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. A Combination Study of PF-04449913 and Azacitidine In 1st Line MDS, AML and CMML Patients

    ... (PD) of PF 04449913 or placebo when combined with azacitidine in patients with previously untreated Intermediate 2 or High ... Associated Drug(s):  Azacitidine Phase:  ...

    Clinical Trial last updated 04/27/2016 - 1:20pm.

  2. The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low

    ... Evaluation of the Efficacy and Safety of Oral Azacitidine plus Best Supportive care versus Placebo and ... Associated Drug(s):  Azacitidine Phase:  ...

    Clinical Trial last updated 04/27/2016 - 9:52am.

  3. Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation

    ... to determine whether post-transplant consolidation with azacitidine combined with donor lymphocyte infusion (DLI) is a safe ... Associated Drug(s):  Azacitidine Phase:  ...

    Clinical Trial last updated 04/28/2016 - 10:42am.

  4. A Trial to Evaluate Two Schedules of MS275 in Combination With 5AC in Elderly Patients With Acute Myeloid Leukemia (AML)

    ... leukemia (AML). Two study drugs will be tested: 5AC (5- azacitidine ) and entinostat. 5AC improves blood counts in 50 - 60% of ... 10 Other Name: MS275 Drug: 5AC Other Name: 5-azacitidine Drug: Entinostat days 10,17 Given orally on days 10, 17 ...

    Clinical Trial last updated 06/03/2016 - 3:09pm.

  5. Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia in Complete Remission (QUAZAR AML-001)

    ... Associated Drug(s):  Azacitidine Phase:  ... Intervention:  Drug: 300 mg Oral Azacitidine Maintenance therapy Drug: Placebo ...

    Clinical Trial last updated 04/29/2016 - 8:39am.

  6. An Open-label Study of Lirilumab (BMS-986015) in Combination With 5-azacytidine (Vidaza) for the Treatment of Patients With Refractory/ Relapsed Acute Myeloid Leukemia

    ... Associated Drug(s):  Azacitidine Phase:  ... dose (MTD) from Phase I. Other Names: Azacitidine 5-aza Vidaza 5-AZC AZA-CR ...

    Clinical Trial last updated 06/06/2016 - 1:26pm.

  7. CC-486 (Oral Azacitidine) Bioequivalence Study in Patients With Solid Tumor or Hematologic Malignancies

    ... Associated Drug(s):  Azacitidine Phase:  ... every 4 weeks for ≤ 6 (four-week) cycles Other Names: Azacitidine for Injection AZA ...

    Clinical Trial last updated 04/28/2016 - 10:47am.

  8. MDS Drug Therapy

    ... (FDA) has approved three medicines to treat MDS: Azacitidine (Vidaza®) for both low- and high-risk patients with all ... Azacitidine (Vidaza®) Azacitidine ...

    Topic section last updated 03/10/2016 - 11:26pm.

  9. Lenalidomide Treatment for Lower Risk Nondeletion 5q Myelodysplastic Syndromes Patients Yields Higher Response Rates When Used Before Azacitidine

    ... Center Clinical Database who received lenalidomide and azacitidine after ESA treatment failure. Rates of erythroid hematologic ... in patients who received lenalidomide first followed by azacitidine (group 1) and those who received lenalidomide after azacitidine ...

    Research Article last updated 12/09/2015 - 8:59am.

  10. AC220 With 5-Aza or Low Dose Cytarabine

    ... of AC220 (quizartinib) that can be given with either 5- azacitidine (azacitidine) or cytarabine to patients with AML or MDS. The goal of the ...

    Clinical Trial last updated 05/03/2016 - 11:11am.